◆ NeutralCVSALGNCAH
Here's How CVS' Improving Balance Sheet Supports Deleveraging
Zacks Investment Research·
CVS Health generated $10.6B in YTD operating cash flow and raised its full-year outlook to at least $11.5B, ending Q2 with $2.7B in cash. The company maintains a leverage ratio of 3.5x and expects improvement as it prioritizes balance-sheet strengthening over share buybacks in 2026-2027. Peers Align Technology and Cardinal Health also demonstrate strong liquidity positions with active capital deployment strategies.
Read Full Article at Zacks Investment Research →